Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 192646, 7 pages
http://dx.doi.org/10.1155/2014/192646
Research Article

Rank-Based miRNA Signatures for Early Cancer Detection

The Microsoft Research - University of Trento Centre for Computational and Systems Biology, Piazza Manifattura 1, 38068 Rovereto, Italy

Received 7 February 2014; Revised 20 May 2014; Accepted 26 May 2014; Published 18 June 2014

Academic Editor: Ivan Merelli

Copyright © 2014 Mario Lauria. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Jay, J. Nemunaitis, P. Chen, P. Fulgham, and A. W. Tong, “miRNA profiling for diagnosis and prognosis of human cancer,” DNA and Cell Biology, vol. 26, no. 5, pp. 293–300, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. G. Reid, M. B. Kirschner, and N. van Zandwijk, “Circulating microRNAs: association with disease and potential use as biomarkers,” Critical Reviews in Oncology/Hematology, vol. 80, no. 2, pp. 193–208, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. H. Schwarzenbach, D. S. B. Hoon, and K. Pantel, “Cell-free nucleic acids as biomarkers in cancer patients,” Nature Reviews Cancer, vol. 11, no. 6, pp. 426–437, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. A. C. Tan, D. Q. Naiman, L. Xu, R. L. Winslow, and D. Geman, “Simple decision rules for classifying human cancers from gene expression profiles,” Bioinformatics, vol. 21, no. 20, pp. 3896–3904, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Subramanian, P. Tamayo, V. K. Mootha et al., “Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 43, pp. 15545–15550, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. F. Iorio, R. Bosotti, E. Scacheri et al., “Discovery of drug mode of action and drug repositioning from transcriptional responses,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 33, pp. 14621–14626, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. “MANTRA,” http://mantra.tigem.it/.
  8. M. Lauria, “Rank-based transcriptional signatures: a novel approach to diagnostic biomarker definition and analysis,” Systems Biomedicine, vol. 1, no. 4, pp. 35–46, 2013. View at Google Scholar
  9. M. E. Smoot, K. Ono, J. Ruscheinski, P.-L. Wang, and T. Ideker, “Cytoscape 2.8: new features for data integration and network visualization,” Bioinformatics, vol. 27, no. 3, pp. 431–432, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. J. H. Morris, L. Apeltsin, A. M. Newman et al., “ClusterMaker: a multi-algorithm clustering plugin for cytoscape,” BMC Bioinformatics, vol. 12, article 436, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Zhao, J. Shen, L. Medico, D. Wang, C. B. Ambrosone, and S. Liu, “A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer,” PLoS ONE, vol. 5, no. 10, Article ID e13735, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Boeri, C. Verri, D. Conte et al., “MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 9, pp. 3713–3718, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. F. Bianchi, F. Nicassio, M. Marzi et al., “A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer,” EMBO Molecular Medicine, vol. 3, no. 8, pp. 495–503, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. A. L. Tarca, M. Lauria, M. Unger et al., “Strengths and limitations of microarray-based phenotype prediction: lessons learned from the IMPROVER diagnostic signature challenge,” Bioinformatics, vol. 29, no. 22, pp. 2892–2899, 2013. View at Google Scholar
  15. J. P. A. Ioannidis, “Microarrays and molecular research: noise discovery?” The Lancet, vol. 365, no. 9458, pp. 454–455, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Goozner, “Duke scandal highlights need for genomics research criteria,” Journal of the National Cancer Institute, vol. 103, no. 12, pp. 916–917, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. J. W. Eaton, D. Bateman, and S. Hauberg, GNU Octave Version 3.0.1 Manual: A High-Level Interactive Language for Numerical Computations, CreateSpace Independent Publishing Platform, 2009, http://www.gnu.org/software/octave/doc/interpreter/.
  18. K. Rhrissorrakrai, J. J. Rice, S. Boue et al., “sbv IMPROVER diagnostic signature challenge: design and results,” Systems Biomedicine, vol. 1, no. 4, pp. 3–14, 2013. View at Google Scholar
  19. L. A. Barroso, J. Dean, and U. Hölzle, “Web search for a planet: the google cluster architecture,” IEEE Micro, vol. 23, no. 2, pp. 22–28, 2003. View at Publisher · View at Google Scholar · View at Scopus